1. Home
  2. AOSL vs AVBP Comparison

AOSL vs AVBP Comparison

Compare AOSL & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AOSL
  • AVBP
  • Stock Information
  • Founded
  • AOSL 2000
  • AVBP 2021
  • Country
  • AOSL United States
  • AVBP United States
  • Employees
  • AOSL N/A
  • AVBP N/A
  • Industry
  • AOSL Semiconductors
  • AVBP
  • Sector
  • AOSL Technology
  • AVBP
  • Exchange
  • AOSL Nasdaq
  • AVBP NYSE
  • Market Cap
  • AOSL 768.5M
  • AVBP 617.4M
  • IPO Year
  • AOSL 2010
  • AVBP 2024
  • Fundamental
  • Price
  • AOSL $24.39
  • AVBP $18.10
  • Analyst Decision
  • AOSL Buy
  • AVBP Strong Buy
  • Analyst Count
  • AOSL 3
  • AVBP 6
  • Target Price
  • AOSL $38.67
  • AVBP $39.00
  • AVG Volume (30 Days)
  • AOSL 509.1K
  • AVBP 191.8K
  • Earning Date
  • AOSL 05-06-2025
  • AVBP 03-03-2025
  • Dividend Yield
  • AOSL N/A
  • AVBP N/A
  • EPS Growth
  • AOSL N/A
  • AVBP N/A
  • EPS
  • AOSL N/A
  • AVBP N/A
  • Revenue
  • AOSL $666,399,000.00
  • AVBP N/A
  • Revenue This Year
  • AOSL $5.32
  • AVBP $63.13
  • Revenue Next Year
  • AOSL $6.62
  • AVBP N/A
  • P/E Ratio
  • AOSL N/A
  • AVBP N/A
  • Revenue Growth
  • AOSL 4.12
  • AVBP N/A
  • 52 Week Low
  • AOSL $19.38
  • AVBP $14.35
  • 52 Week High
  • AOSL $53.29
  • AVBP $36.37
  • Technical
  • Relative Strength Index (RSI)
  • AOSL 33.70
  • AVBP 27.89
  • Support Level
  • AOSL $26.48
  • AVBP $17.89
  • Resistance Level
  • AOSL $28.06
  • AVBP $19.04
  • Average True Range (ATR)
  • AOSL 1.22
  • AVBP 1.00
  • MACD
  • AOSL 0.24
  • AVBP -0.04
  • Stochastic Oscillator
  • AOSL 1.01
  • AVBP 5.56

About AOSL Alpha and Omega Semiconductor Limited

Alpha & Omega Semiconductor Ltd designs, develops and supplies a portfolio of power semiconductors targeting various applications, including personal computers, flat-panel TVs, LED lighting, smartphones, battery packs, consumer and industrial motor controls and power supplies for TVs, computers, servers and telecommunications equipment. It generates revenue mainly from the sale of power semiconductors, consisting of power discretes and power ICs with a presence in Hong Kong, China, South Korea, the United States and other countries.

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

Share on Social Networks: